Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.83M Sell
54,201
-101,345
-65% -$11.4M 0.09% 397
2025
Q4
$17.6M Buy
155,546
+121,105
+352% +$11.6M 0.27% 74
2025
Q3
$2.81M Buy
34,441
+29,540
+603% +$2.71M 0.05% 581
2025
Q2
$506K Sell
4,901
-1,230
-20% -$115K 0.01% 928
2025
Q1
$603K Sell
6,131
-12,690
-67% -$1.69M 0.01% 867
2024
Q4
$2.82M Buy
18,821
+5,561
+42% +$766K 0.07% 494
2024
Q3
$1.73M Buy
13,260
+8,206
+162% +$1.02M 0.05% 607
2024
Q2
$598K Buy
+5,054
New +$537K 0.02% 845
2021
Q2
Sell
-2,776
Closed -$233K 458
2021
Q1
$233K Buy
+2,776
New +$244K 0.07% 350

Other funds holding GKOS

Algert Global's GKOS Position: Q1 2026 in Review

Algert Global reduced its Glaukos (GKOS) stake by 65% in Q1 2026, selling an estimated $11.4M and leaving 54,201 shares worth $5.83M. The position accounts for 0.09% of the portfolio, ranked #397.

Algert Global first reported a position in GKOS in Q1 2021 and has held it in 9 quarters since. The position peaked at $17.6M in Q4 2025. 336 funds tracked by Wall St. Rank hold GKOS as of Q1 2026.

  • Algert Global held 54,201 shares of Glaukos worth $5.83M as of Q1 2026.
  • Algert Global sold 101,345 Glaukos shares in Q1 2026, an estimated $11.4M.
  • Glaukos made up 0.09% of Algert Global's portfolio in Q1 2026, its #397 holding.
  • Algert Global first reported a position in Glaukos in Q1 2021 and has held it in 9 quarters since.
  • Algert Global's Glaukos position peaked at $17.6M in Q4 2025.
  • 336 funds tracked by Wall St. Rank held Glaukos as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.